New treatments for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) enhance patient care with gene therapies and new mechanisms of action on the horizon, explained Casey Koch, PharmD, from Select Health.
Casey Koch, PharmD
Advertisement
Articles by Casey Koch, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Maternal, Child Mortality Higher in the US Compared With Majority of High-Income Countries
2
FDA Approves Second Generic Mifepristone Pill for Abortion
3
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
4
Withdrawal of Aid Could Cause Millions of Lives Lost to HIV
5
